Agid Y - Search Results

1

Nitric oxide synthase and neuronal vulnerability in Parkinson's disease.

Hunot S, Boissière F, Faucheux B, Brugg B, Mouatt-Prigent A, Agid Y, Hirsch EC. Hunot S, et al. Among authors: agid y. Neuroscience. 1996 May;72(2):355-63. doi: 10.1016/0306-4522(95)00578-1. Neuroscience. 1996. PMID: 8737406

2

Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

Kastner A, Hirsch EC, Lejeune O, Javoy-Agid F, Rascol O, Agid Y. Kastner A, et al. Among authors: agid y. J Neurochem. 1992 Sep;59(3):1080-9. doi: 10.1111/j.1471-4159.1992.tb08350.x. J Neurochem. 1992. PMID: 1494900

3

Cholinergic neuronal loss in the globus pallidus of Alzheimer disease patients.

Lehéricy S, Hirsch EC, Hersh LB, Agid Y. Lehéricy S, et al. Among authors: agid y. Neurosci Lett. 1991 Feb 25;123(2):152-5. doi: 10.1016/0304-3940(91)90918-j. Neurosci Lett. 1991. PMID: 1709266

4

Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study.

Javoy-Agid F, Hirsch EC, Dumas S, Duyckaerts C, Mallet J, Agid Y. Javoy-Agid F, et al. Among authors: agid y. Neuroscience. 1990;38(1):245-53. doi: 10.1016/0306-4522(90)90389-l. Neuroscience. 1990. PMID: 1979431

5

Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study.

Thibaut F, Hirsch EC, Raisman R, Javoy-Agid F, Agid Y. Thibaut F, et al. Among authors: agid y. Neuroscience. 1990;37(2):387-98. doi: 10.1016/0306-4522(90)90409-w. Neuroscience. 1990. PMID: 1983469

6

Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsy.

Brandel JP, Hirsch EC, Malessa S, Duyckaerts C, Cervera P, Agid Y. Brandel JP, et al. Among authors: agid y. Neuroscience. 1991;41(1):25-31. doi: 10.1016/0306-4522(91)90197-v. Neuroscience. 1991. PMID: 2057062

7

Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease.

Hirsch EC, Graybiel AM, Agid Y. Hirsch EC, et al. Among authors: agid y. Acta Neurol Scand Suppl. 1989;126:19-22. doi: 10.1111/j.1600-0404.1989.tb01778.x. Acta Neurol Scand Suppl. 1989. PMID: 2575832

8

Neuronal plasticity and Parkinson disease.

Anglade P, Tsuji S, Agid Y, Hirsch EC. Anglade P, et al. Among authors: agid y. Mol Chem Neuropathol. 1995 Feb-Apr;24(2-3):251-5. doi: 10.1007/BF02962152. Mol Chem Neuropathol. 1995. PMID: 7632329 Review. No abstract available.

9

Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?

Mouatt-Prigent A, Agid Y, Hirsch EC. Mouatt-Prigent A, et al. Among authors: agid y. Brain Res. 1994 Dec 30;668(1-2):62-70. doi: 10.1016/0006-8993(94)90511-8. Brain Res. 1994. PMID: 7704619

10

Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal system.

Kastner A, Anglade P, Bounaix C, Damier P, Javoy-Agid F, Bromet N, Agid Y, Hirsch EC. Kastner A, et al. Among authors: agid y. Neuroscience. 1994 Sep;62(2):449-57. doi: 10.1016/0306-4522(94)90379-4. Neuroscience. 1994. PMID: 7830891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

759 results

Search Page

Filters